IDWeek 2019 Annual Conference
Walter E. Washington Convention Center 801 Mount Vernon Pl. NW,, Washington D.C., DC, United StatesAttendees include Richard Alm, CARB-X Alliance Director. IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV […]
Live Webinar: GARDP/REVIVE – Natural products antibiotics: from traditional screening to novel discovery approaches
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesIn this webinar, Olga Genilloud will discuss the role of natural products in current antibiotic discovery. Topics discussed will include: Screening strategies to identify novel antibiotics Current challenges and novel […]
Live Webcast: Drug-Resistant Infections: Confronting an Escalating Crisis
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesDespite drug resistance growing, the development of new antibiotics has slowed. How can policymakers help accelerate the pace of new drug development, and how can all of us—doctors, hospitals, and patients, as well as the agricultural sector—be better stewards of existing drugs? Forum panelists will examine the scope of this looming crisis and look at how changes in policy and practice can help us stay one step ahead of these superbugs.
Institut Pasteur – International Course on Antibiotics and Resistance (ICARE)
Les Pensieres Annecy, FranceSpeakers include Erin Duffy, CARB-X Chief of Research and Development. The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is […]
Challenges in Antimicrobial Resistance – A Conversation with Kevin Outterson
Harvard Chan School of Public Health 677 Huntington Ave FXB 301, Boston, MA, United StatesKevin Outterson, Executive Director of CARB-X, will be speaking at the Harvard Chan School of Public Health. This presentation is sponsored by Harvard Antimicrobial Resistance (HAMR) a subgroup of the […]
World Anti-Microbial Resistance Congress 2019
Renaissance Washington DC Downtown Hotel 999 9th St NW, Washington, DC, United StatesKevin Outterson, Executive Director of CARB-X, will be giving the keynote Address on November 7th, titled "A vision for a health antibiotic R&D ecosystem". Outterson will also be participating on […]
Live Webinar: GARDP/REVIVE – Converting Gram-positive-only compounds into broad-spectrum antibiotics
Webinar 765 Commonwealth Avenue, Boston, MA, United StatesThis webinar by Paul Hergenrother (Department of Chemistry and the Institute for Genomic Biology University of Illinois, US) will detail his research group's efforts to understand compound accumulation in the […]
CRISPR and Gene Editing: The New Frontier in Fighting Infectious Diseases?
JLabs @ Toronto 661 University Ave Suite 1300, Toronto, Ontario, CanadaPresenters include Karen Gallant, Deputy Executive Director of CARB-X. Few technologies have the potential to disrupt and eliminate infectious disease and viral infections– but gene editing, CRISPR in particular, is […]
The 2019 Canada Gairdner Foundation / Ontario International Symposium: Fuelling the Fight against AMR – Global Innovations in Research & Discovery
McMaster University 1280 Main Street W, Hamilton, Ontario, CanadaKevin Outterson, Executive Director of CARB-X, is participating in a special panel discussion titled "When antibiotics fail: An international conversation about the worrisome evidence of impact and what can be […]
FDA Workshop: Enhancing the Clinical Trial Enterprise for Antibacterial Drug Development in the United States
FDA White Oak Campus - Building 31 10903 New Hampshire Ave, Silver Spring, MD, United StatesPresenters include Kevin Outterson, Executive Director of CARB-X, and Erin Duffy, CARB-X Chief of Research and Development. The FDA, IDSA, NIAID and Pew are co-sponsoring this workshop to focus on […]